<< Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Orphan Drug Status for NuCana’s Acelarin 06/17/2019

Expanded Indication for Novo Nordisk’s Victoza 06/17/2019

Latest FDA Warning Letters 06/16/2019

FDA Withdraws 12 No-longer Marketed ANDAs 06/14/2019

FDA Seeks Advisory Panel Consumer Reps 06/14/2019

Lumateperone Tosylate NDA for Schizophrenia to Panel 06/14/2019

FDA Orders Seizure of Life Rising Supplements 06/14/2019

Revised Guide on ANDA Submissions 06/14/2019

Amalgam Concerns Flood Patient Info Docket 06/14/2019

Testing for Biotin Interference in IVDS 06/14/2019

<< Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  Next >>